<code id='0188E6FE94'></code><style id='0188E6FE94'></style>
    • <acronym id='0188E6FE94'></acronym>
      <center id='0188E6FE94'><center id='0188E6FE94'><tfoot id='0188E6FE94'></tfoot></center><abbr id='0188E6FE94'><dir id='0188E6FE94'><tfoot id='0188E6FE94'></tfoot><noframes id='0188E6FE94'>

    • <optgroup id='0188E6FE94'><strike id='0188E6FE94'><sup id='0188E6FE94'></sup></strike><code id='0188E6FE94'></code></optgroup>
        1. <b id='0188E6FE94'><label id='0188E6FE94'><select id='0188E6FE94'><dt id='0188E6FE94'><span id='0188E6FE94'></span></dt></select></label></b><u id='0188E6FE94'></u>
          <i id='0188E6FE94'><strike id='0188E6FE94'><tt id='0188E6FE94'><pre id='0188E6FE94'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:6

          On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West. AI is a big theme this year, everywhere, so on that note, we chat with our AI correspondent — and recent Pulitzer finalist — Casey Ross, who sat down on stage to discuss AI-centered drug discovery with both NVIDIA and Google-backed Isomorphic Labs.

          We also discuss this week’s biotech news, including yet more obesity drug data, this time from Roche, and the closing of Novartis’ acquisition of MorphoSys.

          advertisement

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Bernie Sanders is gearing up to subpoena pharma CEOs
          Bernie Sanders is gearing up to subpoena pharma CEOs

          Sen.BernieSandersisaskinghiscolleaguestoissueasubpoenaoftwopharmaceuticalcompanyCEOs.KevinDietsch/Ge

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          Why Medicare shouldn’t cover every FDA

          AdobeWhoamongusislookingforwardtogettingolderin2024?Notsenators(mostofwhomare65andolder),thetwoleadi